Vivekanand Jha's Publications

About Vivekanand Jha's Publications

Executive Director, The George Institute for Global Health, India
  • PHD
  • WCN23-0146 CHOLECALCIFEROL SUPPLEMENTATION IN CHRONIC KIDNEY DISEASE: EFFECT ON IMMUNE AND VASCULAR FUNCTION

    Kidney International Reports Date published:
  • WCN23-0776 BARRIERS TO ACCESSING ESSENTIAL MEDICINES IN NEPHROLOGY AND RELATED NON-COMMUNICABLE DISEASES: A SCOPING REVIEW

    Kidney International Reports Date published:
  • WCN23-0960 ASSESSMENT OF CAUSES OF DEATH IN A POPULATION REPRESENTATIVE COHORT AT RISK OF CHRONIC KIDNEY DISEASE OF UNKNOWN ORIGIN, USING SmartVA TECHNOLOGY

    Kidney International Reports Date published:
  • WCN23-0576 SOLUBLE UROKINASE RECEPTOR (suPAR) LEVELS AND INCIDENT CHRONIC KIDNEY DISEASE IN STOP-CKDu COHORT

    Kidney International Reports Date published:
  • WCN23-0985 INCIDENTAL DISCOVERY AND EXTRACTION OF MIGRATED GUIDEWIRE FROM RIGHT FEMORAL VEIN CATHETERIZATION: A CASE REPORT

    Kidney International Reports Date published:
  • South Asian Transplant Infectious Disease Guidelines for Solid Organ Transplant Candidates, Recipients, and Donors

    Transplantation Date published:
  • Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)

    American Journal of Nephrology Date published:
  • India’s latest essential medicines list: gaps, strengths and opportunities in evidence-based decision-making

    BMJ Evidence-Based Medicine Date published:
  • Complementary medicine and phospholipase A2 receptor (PLA2R)-related membranous nephropathy-fortuitous or causal?

    Kidney International Date published:
  • National health policies and strategies for addressing chronic kidney disease: Data from the International Society of Nephrology Global Kidney Health Atlas

    PLOS Global Public Health Date published:
  • Climate Change, Heat-Related Acute Kidney Disease, and the Need for Action

    American Journal of Kidney Diseases Date published:
  • Personalized Treatment of PLA2R-Related Membranous Nephropathy

    Clinical Journal of the American Society of Nephrology Date published:
  • PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V)

    Unknown Date published:
  • Hypertension

    Noncommunicable Diseases Date published:
  • A randomized trial of once daily versus twice daily dosing of oral iron in CKD

    Scientific Reports Date published:
  • Patterns of multimorbidity among a community-based cohort in rural India

    Journal of Multimorbidity and Comorbidity Date published: